Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
2 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 168.00 | |
10 mg | In stock | $ 268.00 | |
25 mg | In stock | $ 518.00 | |
50 mg | In stock | $ 752.00 | |
100 mg | In stock | $ 1,060.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 219.00 |
Description | Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. |
In vitro | Lusutrombopag is an agonist of the thrombopoietin receptor that activates platelet production. Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels. |
Synonyms | S-888711, Mulpleta |
Molecular Weight | 591.55 |
Formula | C29H32Cl2N2O5S |
CAS No. | 1110766-97-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (50.72 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lusutrombopag 1110766-97-6 Immunology/Inflammation Proteases/Proteasome Thrombopoietin Receptor Thrombin inhibit Inhibitor S-888711 S888711 Mulpleta S 888711 inhibitor